Quantum BioPharma Ltd. Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019
Quantum BioPharma Ltd. (QNTM) reported Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019 of $5.53 per share for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019 · last filed 2026-03-26
- 2025-09-30: Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019 9 month 5.53 CAD/shares.
- 2025-06-30: Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019 6 month 5.53 CAD/shares.
- 2024-09-30: Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019 9 month 97.50 CAD/shares.
- 2024-06-30: Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019 6 month 97.50 CAD/shares.
CAD/shares
| Period end | Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019 6 month | Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019 9 month |
|---|---|---|
| 2025-09-30 | 5.53 CAD/shares 6-K · filed 2025-11-06 | |
| 2025-06-30 | 5.53 CAD/shares 6-K · filed 2025-08-07 | |
| 2024-09-30 | 97.50 CAD/shares 6-K · filed 2025-11-06 | |
| 2024-06-30 | 97.50 CAD/shares 6-K · filed 2025-08-07 |
USD/shares
| Period end | Weighted Average Exercise Price Of Share Options Exercised In Share-based Payment Arrangement2019 12 month |
|---|---|
| 2025-12-31 | $5.53 20-F · filed 2026-03-26 |
| 2023-12-31 | $84.50 20-F · filed 2026-03-26 |